# US 2025/0059200 A1 · Process for c-h insertion by gem-hydrogenation of an internal alkyne

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0059200 A1
- Document ID: US20250059200A1
- Status: Published application
- Kind: A1
- Application number: 18/720,165
- Filed: 2022-11-29
- Published: 2025-02-20
- Earliest claimed: 2021-12-14
- Assignees: Studiengesellschaft Kohle gGmbH
- Applicants: Studiengesellschaft Kohle gGmbH
- Inventors: Alois FUERSTNER; Sebastian PEIL
- Web page: https://patentgrep.com/patent/US20250059200A1

## CPC

- C07D 491/107: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07F 7/1804: {Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896)}
- B01J 31/2295: {Cyclic compounds, e.g. cyclopentadienyls}
- C07D 205/04: having no double bonds between ring members or between ring members and non-ring members
- C07D 205/12: condensed with carbocyclic rings or ring systems
- C07D 207/08: with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D 207/20: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 211/96: Sulfur atom
- C07D 221/22: Bridged ring systems
- C07D 307/20: Oxygen atoms
- C07D 307/94: spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
- C07D 309/10: Oxygen atoms
- C07D 317/72: spiro-condensed with carbocyclic rings
- C07D 319/06: not condensed with other rings
- C07D 493/08: Bridged systems
- C07D 493/10: Spiro-condensed systems
- C07D 493/14: Ortho-condensed systems
- C07F 7/081: {comprising at least one atom selected from the elements N, O, halogen, S, Se or Te}
- C07F 7/1892: {by reactions not provided for in C07F7/1876 - C07F7/1888}
- B01J 2231/645: of C=C or C-C triple bonds
- B01J 2531/821: Ruthenium
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention is directed to a process for C—H insertion by the gem-hydrogenation of an internal alkyne.

## Claims

### Claim 1

(canceled)

### Claim 2 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the Ru-catalyst is selected from from COD, NBD, (C1 to C12 alkyl)CN, or (C1 to C12 alkyl)2O, tetrahydrofuran, tetrahydropyran, 1,4-dioxane, substituted pyridines, η-arenes, H2 and further common readily dissociating dative ligands known in the art.

### Claim 3 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent, wherein, in Formula (I):
R3 and R4 each independently represent (C1 to C12)alkyl or (hetero)(C1 to C12)alkyl and R3 and R4 optionally form a ring system with each other via the alkyl or the heteroalkyl,
R1 and R2 each independently represent
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl, and
wherein R1 and R2 may form a ring system with each other via the alkyl or the heteroalkyl,
R5 and R6 each independently represent
hydrogen, deuterium,
O(C1 to C12 alkyl), C(═O)—(C1 to C12 alkyl), C(═O)—O—(C1 to C12 alkyl),
NRN1RN2, wherein RN1 represents a protective group selected from an arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a (C1 to C12)alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl), and RN2 represents a C1 to C12 alkyl group, or wherein RN1 and RN2 each represent a C1 to C12 alkyl group, or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R5 and R6 may form a ring system with each other via the alkyl or the heteroalkyl, and
wherein Q represents O or NRN wherein RN represents a protective group selected from an arylsulfonyl group, a (C1 to C12) alkylsulfonyl group, a (C1 to C12) alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl).

### Claim 4 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent, wherein, in Formula (I):
R3 and R4 each independently represent a (C1 to C12)alkyl or hetero(C1 to C12)alkyl and R3 and R4 optionally form a ring system with each other via the alkyl or the heteroalkyl,
R5 and R6 each independently represent hydrogen, deuterium, (C1 to C12)alkyl or hetero(C1 to C12)alkyl,
R1 and R2 each independently represent
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R1 and R2 may form a ring system with each other via the alkyl or the heteroalkyl, and
wherein Q represents O.

### Claim 5 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I)) is hydrogenated in the presence of a Ru-catalyst in an organic solvent, wherein, in Formula (I),
R3 and R4 each independently represent a (C1 to C12) alkyl or hetero (C1 to C12) alkyl and R3 and R4 preferablyoptionally form a ring system with each other via the alkyl or the heteroalkyl,
R1 and R2 each independently represent
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl, wherein
R1 and R2 may form a ring system with each other via the alkyl or the heteroalkyl,
R5 and R6 each independently represent
hydrogen, deuterium,
O(C1 to C12 alkyl), C(═O)—(C1 to C12 alkyl), C(═O)—O—(C1 to C12 alkyl),
NRN1RN2, wherein RN1 represents a protective group selected from a arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl), and RN2 represents a C1 to C12 alkyl group, or wherein RN1 and RN2 each represent a C1 to C12 alkyl group, or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R5 and R6 may form a ring system with each other via the alkyl or the heteroalkyl, and
wherein Q represents NRN wherein RN represents a protective group selected from a arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a alkoxy carbonyl group or —C(═O)(C1 to C12 alkyl), I.

### Claim 6 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent, wherein, in Formula (I):
R1 and R2 each independently represent
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R1 and R2 may form a ring system with each other via the alkyl or the heteroalkyl,
R3 and R4 each independently represent O(C1 to C12)alkyl,
R5 represents hydrogen and R6 represents hydrogen or (C1 to C12)alkyl, and wherein Q represents O.

### Claim 7 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent, wherein, in Formula (I):
R4 and R5 each independently represent (C1 to C12)alkyl or hetero(C1 to C12)alkyl and optionally form a ring system with each other with O or NRN in the ring wherein RN represents a protective group selected from an arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a (C1 to C12)alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl),
R3 represents (C1 to C12)alkyl, hetero(C1 to C12)alkyl or OSi(C1 to C12 alkyl)3,
R6 represents hydrogen, deuterium, (C1 to C12)alkyl or hetero(C1 to C12)alkyl, and
R1 and R2 each independently represent:
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or (C1 to C12)alkyl or hetero(C1 to C12)alkyl, and
wherein Q represents CH2, CH(C1 to C12 alkyl), or C(C1 to C12 alkyl)2.

### Claim 8

(canceled)

### Claim 9 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent optionally selected from aprotic apolar organic solvents.

### Claim 10 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent under a H2 partial pressure of 0.1 to 100 bar.

### Claim 11 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent in a temperature range of 0°° C. to 150° C.

### Claim 12 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in an organic solvent in the presence of a Ru-catalyst in a molar amount of 1 to 10 mol %, referred to the molar amount of the compound of Formula (I).

### Claim 13 (depends on 14)

Process for C—H insertion by gem-hydrogenation of an internal alkyne according to claim 14, wherein the compound of Formula (I) is hydrogenated in the presence of a Ru-catalyst in an organic solvent over a reaction time of 30 min to 600 min.

### Claim 14

A process for C—H insertion by gem-hydrogenation of an internal alkyne comprising hydrogenating a compound of Formula (I) in the presence of a Ru-catalyst in an organic solvent, whereby a compound of Formula (II) is obtained:
wherein in Formulae (I) and (II):
R1 and R2 each independently represent
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R1 and R2 may form a ring system with each other via the alkyl or the heteroalkyl,
R3 and R4 each independently represent
OSi(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl); or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R3 and R4 may form a ring system with each other via the alkyl or the heteroalkyl;
R5 and R6 each independently represent
hydrogen, deuterium,
(C1 to C12)alkyl, C(═O)—(C1 to C12 alkyl), C(═O)—O—(C1 to C12 alkyl),
NRN1RN2, wherein RN1 represents a protective group selected from an arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a (C1 to C12)alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl), and RN2 represents a C1 to C12 alkyl group, or wherein RN1 and RN2 each represent a C1 to C12 alkyl group, or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein R5 and R6 may form a ring system with each other via the alkyl or the heteroalkyl,
wherein R2 and R3 may form a ring system with each other if R1 and R2 do not form a ring with each other, and/or R4 and R5 may form a ring system with each other if R3 and R4 do not form a ring with each other;
wherein Q represents CH2, CH(C1 to C12 alkyl), C(C1 to C12 alkyl)2, O or NRN wherein RN represents a protective group selected from an arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a (C1 to C12)alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl),
with the proviso that, if Q represents CH2, CH(C1 to C12 alkyl), or C(C1 to C12 alkyl)2,
R4 and R5 each independently represent (C1 to C12)alkyl or hetero(C1 to C12)alkyl and form a ring system with each other with O or NRN in the ring wherein RN represents a protective group selected from an arylsulfonyl group, a (C1 to C12)alkylsulfonyl group, a (C1 to C12) alkoxy carbonyl group or —C(═O)—(C1 to C12 alkyl),
R3 represents C1 to C12 alkyl, hetero(C1 to C12)alkyl or OSi(C1 to C12 alkyl)3,
R6 represents hydrogen, deuterium, C1 to C12 alkyl or hetero(C1 to C12)alkyl, and
R1 and R2 each independently represent:
hydrogen, optionally with the proviso that at least one of R1 and R2 is not hydrogen;
Si(C1 to C12 alkyl)3, C(═O)—O—(C1 to C12 alkyl), or
(C1 to C12)alkyl or hetero(C1 to C12)alkyl,
wherein the Ru catalyst is represented by the Formula (III)
wherein Rcp1 to Rcp5 each independently represents C1-C5 alkyl which may be branched or linear, C3-C5 cycloalkyl, ORH or NRH2, C(═O)—O—(C1 to C12 alkyl), C(═O)N(C1 to C12 alkyl)2, X represents Cl, Br, I, OTf, BF4, PF6, O(C1 to C12 alkyl) and L is a ligand, or a di-, tri- or tetramer thereof such as [Cp*RuCl]4.
